Carlsbad, Calif. – Arima Genomics, Inc., a company leveraging 3D genomics to reveal actionable insights that will empower researchers and clinicians seeking to improve human health, today announced the appointment of diagnostics industry veterans John Palma, PhD, and Don Hardison to its Board of Directors. In addition to Dr. Palma and Mr. Hardison, the Arima […]
Gemini BioProducts Holding, Inc. (“GeminiBio” or the “Company”), a portfolio company of BelHealth Investment Partners, LLC (“BelHealth”), a Florida-based healthcare private equity firm, announced the appointment of Cory Stevenson as Executive Chairman of the Board of Directors. Fort Lauderdale, Florida and Sacramento, California – Gemini BioProducts Holding, Inc. (“GeminiBio” or the “Company”), a portfolio company […]
SAN DIEGO — Illumina, Inc. (Nasdaq: ILMN), a global leader in DNA sequencing and array-based technologies, confirmed today that it has received notice from Icahn Partners LP and certain of its affiliates of their intention to nominate three candidates—two current Icahn employees, Jesse Lynn and Andrew Teno, and one former Icahn employee, Vincent Intrieri—for election to the Board […]
Berwyn, Pa. – AMETEK, Inc. (NYSE: AME) today announced the appointment of Daniel J. Ketchum as Vice President and General Manager, MRO Division, effective April 1, 2023. Mr. Ketchum currently serves as Division Vice President and Business Unit Manager for the FMH-PDT business within AMETEK’s Aerospace and Defense Division. “I am pleased to announce Dan’s […]
Senior executive brings deep financial planning and analysis experience to leadership team. DALLAS – Form Bio, the breakthrough computational life sciences platform, today announced the appointment of Linda Murray as Chief Financial Officer. “We are excited to announce this important addition to Form Bio’s leadership team as we enter an exciting time in our development and evolution; […]
CALGARY, AB — Nanalysis Scientific Corp. (“the Company”, TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1), a leader in portable NMR machines and MRI technology for healthcare and industrial applications, announces the appointment of Randall McRae to Chief Financial Officer. “Randall has done an outstanding job since stepping into the interim role over seven months ago,” said Sean Krakiwsky, Founder and CEO of Nanalysis. […]
MARLBOROUGH, Mass. — Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced the appointment of Jennifer Kamocsay as General Counsel. Ms. Kamocsay will oversee all company legal activities and provide strategic guidance and corporate governance oversight. “We are excited to welcome Jennifer to our leadership team,” said Brian McKelligon, Chief Executive Officer […]
Distinguished California Institue of Technology Professor and Howard Hughes Medical Institute Investigator Joins Kytopen Scientific Board to Provide Strategic Guidance on Genome Engineering Platform Development CAMBRIDGE, Mass. — Kytopen, an MIT-spin out and biotechnology company leading advancements in high-throughput cellular and genome engineering platforms, today announced the addition of leading chemical and medical engineering expert Mikhail Shapiro, Ph.D. to […]
OXFORD, England & SAN DIEGO — ONI, the biotechnology company broadly enabling the ability to observe single molecules in living cells with its desktop Nanoimager microscopy platform, today announced that Paul Scagnetti has been appointed as the company’s new CEO, effective February 27, 2023. Along with this leadership change, ONI will begin to implement a […]
Dr Klaus Endress to leave the Supervisory Board by the end of the year; Matthias Altendorf named as successor; Dr Peter Selders will become CEO As previously announced, Dr Klaus Endress will give up his responsibilities as president of the Supervisory Board. He is to be succeeded by CEO Matthias Altendorf. The new CEO of […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
